Africa
Novartis to reveal landmark Phase III results from specialty dermatology portfolio at upcoming EADV 2013 congress
Novartis announced today that new Phase III results from its expanding specialty dermatology portfolio will be presented at the 22nd Congress of the European Association of Dermatology and Venereology (EADV), taking place in Istanbul, Turkey, […]
